www.alk.net
  • Patients
    • What is allergy
      • House dust mite allergy
      •  
      • Pollen allergy
      •  
      • Living with allergy
      •  
      • Socio-economic impact
      •  
    •  
    • What is allergic asthma
    •  
    • How is allergy diagnosed
    •  
    • Treating allergy
    •  
  •  
  • Healthcare Professionals
    • Treating allergy and asthma
    •  
    • Products
    •  
    • Adverse reactions
    •  
    • Initiation of treatment
    •  
    • Clinical trials
    •  
  •  
  • R&D
    • R&D pipeline
    •  
    • Understanding immunotherapy
    •  
    • Research
    •  
    • Congress activities
    •  
    • Clinical data sharing
    •  
  •  
  • Careers
    • Working at ALK
    •  
    • Vacant positions
    •  
  •  
  • Investors
    • Overview
    •  
    • Financial reporting
      • Risk management
      •  
      • Reporting standards
      •  
      • Auditors
      •  
    •  
    • Governance
      • IR policy
      •  
      • Management
      •  
      • Board of directors
      •  
      • Annual general meeting
      •  
      • Annual general meeting (DK)
      •  
    •  
    • News & Events
      • Company Releases
      •  
      • Company releases (DK)
      •  
      • Webcasts & presentations
      •  
      • Investor calendar
      •  
    •  
    • The Share
      • Dividend history
      •  
      • Analyst coverage
      •  
      • Analyst estimates
      •  
      • Shareholder information
      •  
      • Authorizations
      •  
      • ADR Programme
      •  
    •  
    • Contact IR
    •  
    • Management
    •  
    • Board of directors
    •  
    • AGM
    •  
    • AGM (DK)
    •  
    • Nyheder
    •  
    • Nyheder (EN)
    •  
  •  
  • Media
  •  
  • About
    • ALK at a glance
    •  
    • CSR
    •  
    • Production
    •  
    • Global presence
    •  
    • Organisation
    •  
    • History
    •  
    • Values
    •  
    • Owners
    •  
  •  
  • Select country
  •  
Search

News release

Links: 
Company Releases
Company releases (DK)
Webcasts & presentations
Investor calendar

« Back

Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff

May 20, 2020

PDF Version


ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) reports the following transactions:

1.
Details of the person discharging managerial responsibility / person closely associated
a)NameCarsten Hellmann
2.Reason for the notification
a)Position/statusPresident & CEO
b)Initial notification/
amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameALK-Abelló A/S
b)LEI529900SGCREUZCZ7P020
4.Details of the transaction(s): section to be repeated for (i) each type of instrument: (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument

Identification code
Share options

DK0060027142
b)Nature of the transactionPurchase (exercise of share options / purchase of shares – cash settlement)

The purchase price is based on the price at grant adjusted upwards annually by 2.5% less dividend payments
c)Price(s) and volume(s)Price(s)                             Volume(s)
  DKK 4,986,444                                5,900
d)Aggregated information

- Aggregated volume

- Price
 

5,900

DKK 4,986,444
e)Date of the transaction2020-05-19
f)Place of the transactionNASDAQ Copenhagen


1.
Details of the person discharging managerial responsibility / person closely associated
a)NameCarsten Hellmann
2.Reason for the notification
a)Position/statusPresident & CEO
b)Initial notification/
amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameALK-Abelló A/S
b)LEI529900SGCREUZCZ7P020
4.Details of the transaction(s): section to be repeated for (i) each type of instrument: (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument

Identification code
Share options

DK0060027142
b)Nature of the transactionSale (exercise of share options / sale of shares – cash settlement)

The price is calculated on basis of the closing price for the share on the day of exercise
c)Price(s) and volume(s)Price(s)                            Volume(s)
  DKK 10,808,800                               5,900
d)Aggregated information

- Aggregated volume

- Price
 

5,900

DKK 10,808,800
e)Date of the transaction2020-05-19
f)Place of the transactionNASDAQ Copenhagen


                                                                                                            ALK-Abelló A/S



For further information please contact:

Investor Relations: Per Plotnikof, mobile +45 2261 2525


Attachment

  • FM_08_20UK_20052020
  • Email Alerts

    Email Alerts

  • Downloads

    Downloads

  • RSS

    RSS

  • Print

    Print

  • Share

    Share

  • English

    English

  • Search

    Search




Select Country Menu

  • Change Country

Quick Links

  • Contact us
  • News
  • Media
  • Vacant jobs
  • Products

ALK Footer Copyright Text

ALK-Abelló A/S ∙ Bøge Allé 6 ∙ DK-2970 Hørsholm ∙ Denmark ∙ CVR no. 63717916 ∙ T +45 45 74 75 76 Legal disclaimer © ALK ∙ All rights reserved